2m 2m 2m 2m 2m 2m 2m
Protagonist Ther (PTGX)
NASDAQ
$151.44+$3.26 (+2.20%)
Price as of Sep 11, 2026 7:30 PM EDT- $9.6BMarket Cap
- 151.75%1-Year Change
- BiotechnologyIndustry
Protagonist Ther (PTGX)
$151.44+$3.26 (+2.20%)
PTGX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $148.18 | ||
Change | +$3.02 (+2.08%) | ||
Open | $147.18 | ||
High | $150.48 | ||
Low | $145.82 | ||
Previous Close | $145.16 | ||
Volume | 478,038 | ||
30-Day Average Volume | 504,694 | ||
1-Week Change | 1.69% | ||
1-Month Change | -0.07% | ||
1-Year Change | 151.75% | ||
3-Year Change | 685.68% | ||
5-Year Change | 228.70% | ||
Fundamentals | |||
Shares Outstanding | 64.7M | ||
Total Assets | $885.5M | ||
Market Cap | $9.6B | ||
Enterprise Value | $9.2B | ||
Period: QTR TTM FY | |||
Revenue | $213.5M | ||
Net Income | $162.8M | ||
Free Cash Flow | $218.9M | ||
EBIT | $165.1M | ||
EBITDA | $165.5M | ||
Net Working Capital | $770.0M | ||
EPS | $2.29 | ||
Enterprise Value/EBITDA | 55 | ||
Enterprise Value/Revenue | 43 | ||
P/B | 11 | ||
P/E | 65 | ||
PEG | 0 | ||
Price/Free Cash Flow | 44 | ||
Price/Operating Cash Flow | 44 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue